Bentham Science Logo

Current Drug Targets

Volume 20, 16 Issues, 2019
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access

Ranking and Category

  • 131st of 267 in

    Pharmacology & Pharmacy

Order Your Article Before Print

Contents

Current Drug Targets, Volume 19 - Number 11


Review Article

Adipocytes and Abdominal Aortic Aneurysm: Putative Potential Role of Adipocytes in the Process of AAA Development

, 19(11): 1228 - 1232

Hirona Kugo, Tatsuya Moriyama and Nobuhiro Zaima*


DOI: 10.2174/1389450119666180115164103



Review Article

Osteoclastogenesis in Abdominal Aortic Aneurysms: A New Therapeutic Target

, 19(11): 1233 - 1240

Alexander D. Leung and Dai Yamanouchi*


DOI: 10.2174/1389450118666170925155044



Review Article

Fenofibrate and Telmisartan in the Management of Abdominal Aortic Aneurysm

, 19(11): 1241 - 1246

Sophie E. Rowbotham, Smriti M. Krishna, Corey S. Moran and Jonathan Golledge*


DOI: 10.2174/1389450119666171227224655



Review Article

Therapeutic Applications of Prostaglandins and Thromboxane A2 Inhibitors in Abdominal Aortic Aneurysms

, 19(11): 1247 - 1255

Audrey Courtois*, Georgios Makrygiannis, Jean-Paul Cheramy-Bien, Audrey Purnelle, Bernard Pirotte, Jean Michel Dogne, Julien Hanson, Jean-Olivier Defraigne, Pierre Drion and Natzi Sakalihasan


DOI: 10.2174/1389450119666171227224314



Abdominal Aortic Aneurysm (AAA): Is There a Role for the Prevention and Therapy Using Antioxidants?

, 19(11): 1256 - 1264

Joël Pincemail*, Jean-Olivier Defraigne, Audrey Courtois, Adelin Albert, Jean-Paul Cheramy-Bien and Natzi Sakalihasan


DOI: 10.2174/1389450118666170918164601



Review Article   Open Access

Current Status and Perspectives on Pharmacologic Therapy for Abdominal Aortic Aneurysm

, 19(11): 1265 - 1275

Koichi Yoshimura*, Noriyasu Morikage, Shizuka Nishino-Fujimoto, Akira Furutani, Bungo Shirasawa and Kimikazu Hamano


DOI: 10.2174/1389450119666171227223331



Review Article

Role of the LDL Receptor-Related Protein 1 in Regulating Protease Activity and Signaling Pathways in the Vasculature

, 19(11): 1276 - 1288

Dianaly T. Au, Allison L. Arai, William E. Fondrie, Selen C. Muratoglu* and Dudley K. Strickland*


DOI: 10.2174/1389450119666180511162048



Review Article

Inflammatory Cells and Proteases in Abdominal Aortic Aneurysm and its Complications

, 19(11): 1289 - 1296

Haiying Jiang, Takeshi Sasaki, Enze Jin, Masafumi Kuzuya and Xian Wu Cheng*


DOI: 10.2174/1389450119666180531103458



Review Article

Optimal Time for Pharmacological Treatment of Abdominal Aortic Aneurysm

, 19(11): 1297 - 1301

Yasunori Iida*, Shigeharu Sawa and Hideyuki Shimizu


DOI: 10.2174/1389450119666171227225008



Review Article

Current Theories and Clinical Trial Evidence for Limiting Human Abdominal Aortic Aneurysm Growth

, 19(11): 1302 - 1308

Jing Yu, Shuai Liu, Jianhua Huang and Wei Wang*


DOI: 10.2174/1389450118666171113114310



Review Article

Drug Therapy for Abdominal Aortic Aneurysms Utilizing Omega-3 Unsaturated Fatty Acids and Their Derivatives

, 19(11): 1309 - 1317

Daisuke Akagi*, Katsuyuki Hoshina, Toshiaki Watanabe and Micheal S. Conte


DOI: 10.2174/1389450118666171013101815



Review Article

Pathogenic and Therapeutic Significance of Angiotensin II Type I Receptor in Abdominal Aortic Aneurysms

, 19(11): 1318 - 1326

Baohui Xu*, Haojun Xuan, Yasunori Iida, Masaaki Miyata and Ronald L. Dalman


DOI: 10.2174/1389450119666180122155642



Review Article

Hypoperfusion of the Aortic Wall Secondary to Degeneration of Adventitial Vasa Vasorum Causes Abdominal Aortic Aneurysms

, 19(11): 1327 - 1332

Hiroki Tanaka*, Naoki Unno, Yuko Suzuki, Hideto Sano, Tatsuro Yata and Tetsumei Urano


DOI: 10.2174/1389450119666180122154409



General Review Article

Anesthetics Mechanisms: A Review of Putative Target Proteins at the Cellular and Molecular Level

, 19(11): 1333 - 1343

Danuh Kim, Hyun Joo Kim and Seunghyun Ahn*


DOI: 10.2174/1389450119666180502112029



General Review Article

The Case for Cannabinoid CB1 Receptors as a Target for Bronchodilator Therapy for β-agonist Resistant Asthma

, 19(11): 1344 - 1349

John C. Ashton* and Robert J. Hancox


DOI: 10.2174/1389450118666170615101220





Editor-in-Chief

Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
USA

View Full Editorial Board

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Track Your Manuscript:


Scopus CiteScore Metrics: 1.18

Related Journals

Related eBooks

eBooks Catalog